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Recombinant DNA domain remains a dependant of effective use of recombinant proteins in many applications 
but its production remains an area of concern due to DNA vector and production path. This work is aimed at 
studying the generation and replication of the recombinant DNA molecule using PI3K C2β C2 domain and 
glutathione s-transferase (GST) which expressed in pGEX-2T vector. The molecular cloning technique was 
employed to generate a recombinant DNA molecule. PI3K C2β C2 domain of  isoform PI3K C2β belonging to 
class PI3K C2 of Phosphoinositide-3-Kinase (PI3K) family was used and the effective digestion of pGEX-2T 
vector was studied using restricted enzymes (RE) of EcoR I and Sma I with binding partners location. The 
ligated product of recombinant DNA was obtained after successful doubled digestion of pGEX-2T vector. The 
best transformation of competent bacterial cells was obtained at molar ratio of 5:1 for RE digested vector insert 
DNA and vector DNA. The recombinant DNA can be employed may be used in treatment of non – 
communicable diseases such as cancer and diabetes. 




Recombinant DNA molecules are living entities created when at least two DNA molecules from different species 
bind together in a specific host [1] by a process known as molecular cloning. This process is usually employed 
directly after amplification and replication of the DNA sequence of the gene was performed by using polymerase 
chain reaction (PCR) [2 - 5]. The recombinant DNA molecules are of utmost importance to science and 
medicine. It can be used for the diagnosis, prevention or treatment of some diseases such as diabetics, AIDS or 
some types of cancer; production of hormones, vaccines or antibiotics; application of gene therapy; forensic 
research and experimental studies [6 - 10]. The synthesis of recombinant DNA sequence of gene especially PI3K 
C2β C2 domain remains an area of concern for biomedical professionals so as to enhance health care delivery. 
The enzyme donor as reported in [11] is located at the C terminus that is attached to the PI3K core structure 
involved in Ca2+ dependent or Ca2+ independent phospholipid membrane binding, thereby, mediate protein-
protein interaction [12]. The enzyme donor is a portion of the second isoform of the second class belonging to 
the family of enzyme, PI3K. The size of this domain is about 126 amino acid residues and bears 378 base pairs. 
Arcaro et al. [13] reported that PI3K C2β C2 domain may bind Ca2+ with low affinity when compared to PI3K 
C2α domain of synaptotagmin and its absence could result in raising the activity of lipid kinase. Some other 
domains present in this isoform also tend to be involved in protein-protein interaction as well as fuse to 
membrane lipids [14]. The importance of PI3K C2β such as membrane trafficking [11], cell migration on some 
epithelial lines [15] and differentiation of HL-60 hematopoietic cells by retinoic acid [16] cannot be 
underestimated, yet there is still limited report on the activities carried out by PI3K C2β C2 domain only. The 
vector, pGEX-2T used for molecular cloning consists of bacterial plasmid of about 4948 base pair with multiple 
cloning sites as well as a selectable marker, ampicillin [17, 18] as shown in Figure 1. 
 
Figure 1: A schematic diagram of pGEX-2T vector [17, 18]. 
The circular cloning vector generates high level intracellular expression of whole genes or gene fragments 
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when bound to Schistosoma japonicum Glutathione S-transferase (GST) [18]. GST is a 26kDa protein usually 
expressed in Escherichia coli (E. coli) with full enzymatic activity and GST fusion system is mostly employed to 
purify and detect fusion proteins already produced in E. coli. Amplification of the enzyme donor and gene of 
interest has already been reported by Banigo and Azeez [11]. Effective generation and utilization of GST fusion 
protein required a preliminary step of genetic engineering which will apparently be used to determine some 
binding partners; detect some diseases associated with the gene and also develop better therapeutic tools. 
Furthermore, researchers have reported the performance of proteins such as DNA-protein interaction [19], 
protein-protein interaction [20 - 22], and the production of vaccines [23, 24]. This work is aimed at generating 
and replicating the recombinant DNA molecule using PI3K C2β C2 domain and glutathione s-transferase (GST) 
expressed in pGEX-2T vector.  
 
2. Materials and Methods 
Recombinant DNA technology utilizes some biological agents such as DNA insert, cloning vector DNA, 
restriction endonucleases, DNA ligases, DNA polymerase and host organism to achieve its goal.  
 
2.1 Materials for Restriction Enzyme Digestion  
Restriction enzymes (Sma I and E.coR I enzymes), Buffer A, autoclaved Milli-Q-purified water and DNA 
samples were used for restricted enzymes (RE) digestion of pGEX-2T vector and vector insert as listed in Table 
1. 
Table 1: Materials needed for RE digestion 
Materials pGEX-2T vector Vector DNA insert 
JD 
Buffer A 3 µl 3 µl 
Autoclaved Milli-Q-purified water 20, 22, 24µl 20/22 µl 
pGEX-2T vector DNA 3µl - 
DNA insert - 5 µl 
Sma I and E.coR I enzymes 4 µl total 1 µl each 
Total volume 30 µl 30 µl 
 
2.2 Restriction enzyme digestion of DNA insert and pGEX-2T vector  
The purified amplicons, JD 89/88, 90/88 and 91/88 of PI3K C2β C2 domain obtained from Biomedical 
Laboratory, University of Bedfordshire apparently generated by [11] were digested with both Sma I and E.coR I 
restriction enzymes (RE). Buffer A was used for Sma I and E.coR I. The master mix comprising of the purified 
amplicon (DNA insert), Buffer A and Autoclaved Milli-Q-purified water was mixed with both enzymes or 
without the enzymes (negative control) in their right proportions and centrifuged at 13,200rpm for 30s to have a 
complete reaction. The master mix containing the pGEX-2T tagged as 438 and 449 samples were incubated at 
25ºC for 90mins and at 37ºC for 60mins, respectively. Afterwards, the RE digested PCR products were analysed 
using 1% Agarose gel.  
 
2.3 Purification of PCR products after restriction enzyme digestion 
The double digested amplicons (DNA inserts) were purified using QIAquick PCR purification kit (QIAGEN 
Inc., Valencia, CA) as described by Banigo and Azeez [11]. The Buffer PB containing guanine chloride, 
denaturant, protein detergent and DNA inserts were mixed, placed into a QIAquick column, and centrifuged at 
13,200 rpm for 50s to bind DNA. The Buffer PE was aliquoted into the QIAquick column and centrifuged at 
13,200 rpm for 50s to elute DNA. Fluid was discarded and the QIAquick column was placed in a fresh tube. The 
product was centrifuged at 13,200 rpm for 50s and eluted with autoclaved Milli-Q-purified water. The purified 
double digested amplicons was analysed using 1% Agarose gel. 
 
2.4 Gel extraction of RE digested pGEX-2T vector fragment and purification of DNA 
The digested DNA fragments seen on the agarose gel were isolated, excised with a brand new scalpel on a Bench 
top 3UVTM trans-illuminator and transferred into tubes. The QIAquick Gel extraction kit Protocol (QIAGEN 
Inc., Valencia, CA) was used for extraction and purification of the double digested vector DNA fragment. The 
gel slice was weighed in the micro - centrifuge tube. The excised gel and Buffer QG in the ratio of 3:1 were 
added, incubated at 50ºC for 10 mins to dissolve the gel completely and confirmed that the colour of the 
solubilised gel samples was yellow. Isopropanol was added to the sample in the tubes, then transferred into a 
QIAquick column and centrifuged for 1min to bind DNA. The soluble DNA was extracted and analysed using 
1% Agarose gel. 
 
2.5 DNA Ligation of both pGEX-2T vector DNA and DNA insert  
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The DNA ligation was obtained from the combination of constituents presented in Table 2. Control sample 
comprised of the vector only and ligase (15µl without the insert). The reaction mix was incubated at 160C 
overnight in a SANYO incubator supplied by Patterson Scientific. The cleavage of digested pGEX – 2T vector 
and ligation of vector DNA and DNA insert are shown in Figure 2.  
Table 2: The constituents of DNA ligation 
Materials Volume (µL) 
RE digested vector DNA 1.0 
RE digested vector insert DNA 5.0 
T4 DNA ligase buffer (10x) 2.0 
T4 DNA ligase 1.0 
PEG 4000 solution (50%) 2.0 
Autoclaved Milli-Q-purified water 9.0 
Total volume 20.0 
  
 
Figure 2:  The cleavage of pGEX-2T vector and ligation of the vector DNA and DNA insert 
(PI3K C2β C2 domain) at specific restriction sites. 
 
2.6 Transformation of competent XL-1 cells.  
Competent XL-1 cells at 800C was obtained from Biomedical Laboratory, University of Bedfordshire and 
thawed on ice. Luria Broth (LB) agar plates containing antibiotic were warmed up in the incubator at 370C after 
being removed from 40C. 5µl of recombinant DNA molecule (pGEX-2T vector + DNA insert) and 100µL of 
competent cells were mixed using a sterile technique in a centrifuge tube shaker and placed on ice for about 
15mins.Terrific Broth (TB) without antibiotics was added to each tube containing the transformation mixture and 
incubated at 370C for 60mins to allow bacteria grow. The samples were centrifuged for 1min at 13,000rpm and 
some volumes of supernatant was aspirated leaving about 50µL medium above the pellet. The cells were re-
suspended and spread around the agar plates containing antibiotics to create a bacterial lawn and incubated at 
370C for 16 hrs. 
 
3. Results and Discussion 
Figure 3 shows the RE digestion of the vector with a single enzyme, EcoR I and pGEX-2T. It can be observed 
that the Lane 1 tagged as SM (selectable marker) has bands of 1Kb (Kilo base) molecular weight marker. The 
pGEX-2T tagged with 438 and 449 prepared with restricted enzyme and buffer A represent Lane 2 and 3, 
respectively, formed a bright and sharp band at 5kb but not properly digested. The Lane 4 and 5 which represent 
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pGEX-2T of 438 and 449 without EcoR I but with buffer A, respectively, show a fainted band formation at 3kb. 
This indicated that restricted enzyme EcoR I aids the digestion of pGEX-2T due to increase in band width. The 
pGEX-2T without any reagent and restricted enzymes represented by lane 6 and 7, respectively, shows no 
formation of band. The absence of band in lane 6 and 7 may be attributed to the absence of buffer A and 
restricted enzyme activity.  
 
Figure 3: Single digestion of two pGEX-2T vector preparations with E.coR I run on 1% agarose gel. 
After examination of single digestion of pGEX-2T vector with EcoR I, the result shows the important of 
restricted enzyme (E.coR1) and buffer A in the digestion. The effect of both enzymes in digestion of pGEX-2T 
vector is presented in Figure 4. The EcoRI and Sma1, respectively, did not properly digest the pGEX-2T vector 
at 5kb as observed in lane 2 and 3 of Figure 4. This may be attributed to impurity of pGEX-2T vector. EcoRI 
gave a sticky end as presented in Figure 5 while SmaI gave a blunt end as shown in Figure 6. Lanes 2 and 3 
represent control samples of pGEX-2T containing a single enzyme of E.coRI and SmaI, respectively. However, 
the use of combination of two restriction enzymes (EcoRI and SmaI) for breaking down of pGEX-2T vector or 
amplicons is called double digestion and both REs used, gave a clear cut of vector DNA at 5kb. This may be 
attributed to the effectiveness and synergistic effect of double restriction enzymes as Sma I worked at 25ºC for 
90mins and E.coR I worked at 37ºC for the optimal digestion activity. Lanes 4, 5 and 6 represent the pGEX-2T 
vector with both enzymes, show a clear cut product and sharp band at 5kb compared to lanes 2 and 3, 
respectively. This indicated the master mix with both REs gave a less product digestion. 
 
Figure 4: Effect of double digestion of pGEX-2T vector using EcoR I and Sma I REs on 1% agarose gel. 
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Figure 5: Cleavage of DNA with EcoR I 
 
 
Figure 6: Cleavage of DNA with Sma I 
Figure 7 shows the purified double digested PCR and pGEX-2T vector. Figure 7 and 8 clearly explain the 
sequence of the amplicons inserted into the plasmid in one direction, as both REs were adjacent to each other in 
the polylinker region. Lanes 2, 3 and 4 show clear PCR products (containing the different primers) at  ̴ 400bp 
and the estimated concentration of their DNA is between 80 - 100ng, whereas lane 5 contains the pGEX-2T 
vector of about 5kb in size with clear DNA of about 20ng of DNA concentration as compared to the latter. The 
essence of purifying pGEX-2T vector DNA, is to remove debris from single copy of genomic DNA isolated 
from an infected organism in the products. The variation in thickness of the DNA bands of PCR primers may be 
attributed to the level of concentration of purity of the DNA product. The thicker the band, the higher the 
concentration of the impurity in the DNA and vice versa.  However, the purified double digested pGEX-2T 
obtained exhibits high purity. This is in agreement with the report of Banigo and Azeez [11].  
 
Figure 7: Purified DNA products obtained from the RE digestion of PCR products (DNA insert)  
and pGEX-2T vector with EcoR I and Sma I on 1% agarose gel. 
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Figure 8: Location of the polylinker region between Sma I and EcoR I restriction enzymes  
sites in pGEX-2T vector 
After a successful double digestion of both pGEX-2T vector and vector insert, blunt - end ligation protocol 
from (Thermo Scientific, Lot 00102127) was employed to aid ligation. All the required reagents and temperature 
at the specific time were used during ligation. It was expected that the sticky end would ligate faster due to 
compatibility than blunt end. Essential co-factors in the DNA ligase such as ATP supplied energy to aid ligation. 
The result obtained from ligation could only be ascertained after transformation and sequencing was achieved.  
Figure 9 shows the transformation of competent XL-1 cells with the ligated product. The absence of colony 
was observed on the LB Agar + Ampicillin plate after several repeats of transformation of XL-1 with ligated 
products. Re-checking of all reagents and procedures was done starting from the temperature used to shock the 
cells at 420C, fresh ampicillin and purified DNA products to the molar ratio. Poor transformation of competent 
XL-1 cells with the ligated product was obtained for molar ratio of 3:1. This may be attributed to incorrect molar 
ratio of both vector insert DNA and vector DNA used as reported by Williams et al [25]. The ratio 5:1 gave the 
best transformation in the presence of blunt - end ligation and also used for ligation mixture with competent cells 
(20%:100%). The recombinant PI3K C2β C2 domain DNA sequence was achieved follows the path presented in 





Transformation of pGEX-2T vector 
into competent XL-1 cells 
 
 
                                                                Spread cells on 












Figure 9: Schematic representation of the products obtained from ligation of the pGEX-2T vector + insert and 
transformation of XL-1 cells with the recombinant DNA molecule. 
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Figure 10: A schematic representation of the cloning of PI3K C2β C2 domain DNA sequence, expected  
expression and purification of recombinant C2 domain protein (GST+PI3K C2β C2 domain). 
 
4. Conclusion 
Ligated product was obtained from successful double digested products. Moreover, doubled of pGEX-2T vector 
using RE digestion proved to play a significant role in molecular cloning as a crucial area of biotechnology. It is 
uncertain if ligation worked as expected due to the absence of no colonies formed in the agar plates during 
transformation using molar ratio of 3:1. The produced recombinant DNA molecule was achieved at molar ratio 
of 5:1 and it can be employed for the production of recombinant proteins which will apparently be used in 
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